POLYMED.NS Cash Flow
Poly Medicure Ltd.
Profit & Loss Balance Sheet Cash Flow
Cash Flow · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 23:43
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Net Cash from Operating Activities | ₹1.91 Bn | ₹2.66 Bn | ₹2.41 Bn | ₹2.41 Bn | CashFlowsFromUsedInOperatingActivities |
| Net Cash from Investing Activities | ₹-1.79 Bn | ₹-2.41 Bn | ₹-11.91 Bn | ₹-2.25 Bn | CashFlowsFromUsedInInvestingActivities |
| Net Cash from Financing Activities | ₹-0.13 Bn | ₹-0.20 Bn | ₹9.53 Bn | ₹0.20 Bn | CashFlowsFromUsedInFinancingActivities |
| Effect of Exchange Rate Changes | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹0.01 Bn | EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| Net Increase/(Decrease) in Cash | ₹-0.01 Bn | ₹0.05 Bn | ₹0.03 Bn | ₹0.37 Bn | IncreaseDecreaseInCashAndCashEquivalents |
| Cash and Cash Equivalents (Closing) | ₹0.08 Bn | ₹0.07 Bn | N/A | N/A | CashAndCashEquivalentsCashFlowStatement |
Every figure above is the exact value of the named XBRL element from POLYMED.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).